We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized, Double-Blind, Trial Comparing Epinephrine Versus Phenylephrine as a Vasoconstrictor in Regional Anesthesia for Upper Extremity Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00225043
Recruitment Status : Completed
First Posted : September 23, 2005
Last Update Posted : June 2, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:
The study involves research, the purpose of which is to compare three different drug mixtures (Epinephrine, Phenylephrine 25 µg, or Phenylephrine 50 µg). Specifically, how long each medicine lasts will be studied.

Condition or disease Intervention/treatment
Healthy Drug: Epinephrine/phenylephrine

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Study Start Date : June 2005
Primary Completion Date : August 2007
Study Completion Date : August 2007


Arms and Interventions


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Shoulder surgery with regional anesthesia

Exclusion Criteria:

  • Shoulder surgery with general anesthesia unhealthy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00225043


Locations
United States, New York
New York Methodist Hospital
Brooklyn, New York, United States, 11215
Sponsors and Collaborators
New York Methodist Hospital
Investigators
Principal Investigator: Joel Yarmush, MD, MPA New York Methodist Hospital
More Information

Responsible Party: Joel Yarmush, New York Methodist Hospital
ClinicalTrials.gov Identifier: NCT00225043     History of Changes
Other Study ID Numbers: 299
First Posted: September 23, 2005    Key Record Dates
Last Update Posted: June 2, 2008
Last Verified: May 2008

Additional relevant MeSH terms:
Epinephrine
Racepinephrine
Phenylephrine
Oxymetazoline
Epinephryl borate
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Adrenergic beta-Agonists
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Anti-Asthmatic Agents
Respiratory System Agents
Mydriatics
Sympathomimetics
Vasoconstrictor Agents
Cardiotonic Agents
Nasal Decongestants
Adrenergic alpha-1 Receptor Agonists
Protective Agents